Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-EN
Language French English
Date Updated 2019-12-02 2019-12-02
Drug Identification Number 00042560 00042560
Brand name MAXIDEX MAXIDEX
Common or Proper name MAXIDEX 0.1% SUSP 5ML MAXIDEX 0.1% SUSP 5ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients DEXAMETHASONE DEXAMETHASONE
Strength(s) 0.1% 0.1%
Dosage form(s) SUSPENSION SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ML 5ML
ATC code S01BA S01BA
ATC description ANTIINFLAMMATORY AGENTS ANTIINFLAMMATORY AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2019-10-23 2019-10-23
Estimated end date 2020-03-31 2020-03-31
Actual end date
Shortage status Actual shortage Actual shortage
Company comments Supply interruption Supply interruption
Health Canada comments